Evidence map›Paper›PMID 25451127›Full record

ReviewBrain research2015

Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging.

Edythe D London, Milky Kohno, Angelica M Morales, Michael E Ballard

Open access · greenAbstract readReview
In one paragraph

Review in Brain research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 3 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 3 syntheses or guidelines pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Top-Down of Prefrontal Cortex to the Hippocampus Glutamatergic Pathway Regulates Reward Memory of Methamphetamine.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Fusion Model Using Resting Neurophysiological Data to Help Mass Screening of Methamphetamine Use Disorder.IEEE journal of translational engineering in health and medicine · 2025
    Article
  18. Review
  19. Article
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Edythe D LondonDepartments of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90024; Departments of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California 90024; Departments of Brain Research Institute, University of California, Los Angeles, Los Angeles, California 90024. Electronic address: elondon@mednet.ucla.edu.
Milky KohnoDepartments of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90024.
Angelica M MoralesDepartments of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90024.
Michael E BallardDepartments of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90024.
University of California, Los Angeles · US

Funding

UCLA Training Program in Translational Neuroscience of Drug Abuse (TNDA)T32DA024635 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LARA A. RAY, Kate M Wassum · 2008 to 2026
$6.2M
Neural substrates of impulsive behavior in methamphetamine dependenceF31DA033117 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MORALES, ANGELICA MARIE · 2012 to 2013
$70k
Modulators of maladaptive decision-making in methamphetamine dependenceF31DA033120 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KOHNO, MILKY · 2012 to 2013
$50k
ASSOCIATION BETWEEN ILLICIT DRUG USE AND BEHAVIORAL REPERTOIRE IN ADOLESCENTSZ01DA000331 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI ANTHONY, J · 1994 to 1995
–
CSRD VA IK2 CX001790NIDA NIH HHS F31 DA0331-17NIDA NIH HHS F31 DA033117NIDA NIH HHS F31 DA033120NIDA NIH HHS F31 DA033120-02NIDA NIH HHS T32 DA024635
6 · The paper itself

Abstract

Despite aggressive efforts to contain it, methamphetamine use disorder continues to be major public health problem; and with generic behavioral therapies still the mainstay of treatment for methamphetamine abuse, rates of attrition and relapse remain high. This review summarizes the findings of structural, molecular, and functional neuroimaging studies of methamphetamine abusers, focusing on cortical and striatal abnormalities and their potential contributions to cognitive and behavioral phenotypes that can serve to promote compulsive drug use. These studies indicate that individuals with a history of chronic methamphetamine abuse often display several signs of corticostriatal dysfunction, including abnormal gray- and white-matter integrity, monoamine neurotransmitter system deficiencies, neuroinflammation, poor neuronal integrity, and aberrant patterns of brain connectivity and function, both when engaged in cognitive tasks and at rest. More importantly, many of these neural abnormalities were found to be linked with certain addiction-related phenotypes that may influence treatment response (e.g., poor self-control, cognitive inflexibility, maladaptive decision-making), raising the possibility that they may represent novel therapeutic targets.

Indexed as

Amphetamine-Related DisordersAnimalsBrainCentral Nervous System StimulantsHumansMethamphetamineNeuroimagingCentral Nervous System StimulantsMethamphetamineAddictionCorticostriatal circuitryDiffusion tensor imagingMagnetic resonance imagingMethamphetaminePositron emission tomography

Identifiers

PMID25451127
PMCPMC4418947
OpenAlexW1989816896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.